| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |